Oxford tests new malaria shot schedule
NCT ID NCT06320535
Summary
This early-stage study is testing whether giving multiple increasing doses of the R21 malaria vaccine is safe and triggers a good immune response. It involves 36 healthy UK adults who have never had malaria. Researchers will compare this new multi-dose schedule against the standard two-dose approach to see which works better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre for Clinical Vaccinology and Tropical Meducine, Churchill Hospital, University of Oxford
Oxford, Oxfordshire, OX3 7LE, United Kingdom
-
University Hospitals Bristol and Weston NHS Foundation Trust
Bristol, BS2 8HW, United Kingdom
Conditions
Explore the condition pages connected to this study.